Immune disorders caused by defects in the caspase cascade
- 49 Downloads
In the immune system, lymphocyte activation by antigen is followed by cell proliferation and induction of effector functions. Subsequently, physiologic cell-death signals are induced, resulting in removal of expanded effector-cell populations, to maintain homeostasis. Caspases are intracellular participants in both activation responses and cell death by apoptosis. Targets of caspases include inflammatory activators and also other members of the caspase family that mediate apoptosis. Caspase-8 and caspase-10 participate in the protease cascade following cell surface CD95 engagement by its ligand. Humans with defects in these caspases were initially evaluated for the autoimmune lymphoproliferative syndrome because of their spleen and lymph node enlargement. Although both caspase-8- and caspase-10-deficient individuals had impaired apoptosis, those with caspase-8 deficiency, who also had immunodeficiency, had additional defects in activation of lymphocytes and natural killer cells. These disorders help to define the importance and specificity of the caspase proteases in intracellular signaling pathways.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 3.Straus SE, Jaffe ES, Puck JM, et al.: The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood 2001, 98:194–200. This paper demonstrates the elevated risk for patients with ALPS to develop lymphomas of diverse histology.PubMedCrossRefGoogle Scholar
- 4.Jackson CE, Hsu AP, Fischer RE. et al.: Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance. Am J Hum Genet 1999, 64:1002–1014. This manuscript displays the spectrum of ALPS type Ia mutations, highlighting the dominant nature of in vitro apoptosis defects while exploring the genotype/phenotype variation underlying differences in severity and penetrance.PubMedCrossRefGoogle Scholar
- 9.Wang J, Zheng L, Lobito A, et al.: Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 1999, 98:47–58. This is the first demonstration of human disorders associated with caspase-10 defects; it also defines the cellular impairments in apoptosis of both T cells and dendritic cells caused by dominant mutations of caspase-10.PubMedCrossRefGoogle Scholar
- 10.Chun HJ, Zheng L, Ahmad M, et al.: Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 2002, 419:395–399. This is the first demonstration of an immunodeficiency and apoptosis disorder in two siblings with a homozygous defect in caspase-8; the importance of this paper is the linking of caspase-8 to activation functions of NK and T cells in addition to the known role of caspase-8 in apoptosis.PubMedCrossRefGoogle Scholar
- 14.Johns Hopkins University and National Center for Biotechnology Information: Online Mendelian Inheritance in Man, OMIM. http://www.ncbi.nlm.nih.gov/omim/ This is an outstanding comprehensive and continuously updated resource for information and references on human disease genes.Google Scholar
- 28.Gronbaek K, Dalby T, Zeuthen J, et al.: The V410I (G1228A) variant of the caspase-10 gene is a common polymorphism of the Danish population. Blood 2000, 95:2184–2185. This paper shows that there are genetic variants of caspase-10 in the general population. Although not disease-associated in the heterozygous state, these variants might act in conjunction with other risk factors to have functional significance in individuals who are predisposed to autoimmune diseases.PubMedGoogle Scholar
- 30.Wang J, Chun HJ, Wong W, et al.: Caspase-10 is an initiator caspase in death receptor signaling. Proc Nat Acad Sci USA 2001, 98:13884–13888. This paper uses primary cells with caspase-8 deficiency to prove that caspase-10, in the absence of caspase-8, can initiate the apoptotis response.PubMedCrossRefGoogle Scholar
- 31.Sprick MR, Rieser E, Stahl H, et al.: Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signaling complexes in a FADD-dependent manner but cannot functionally substitute caspase-8. EMBO J 2002, 4520–4530. This study probes similarities and differences between caspase-8 and caspase-10; although each can be recruited to cytoplasmic domains of death receptors and can initiate apoptosis, their functions are not completely overlapping.Google Scholar